))
Episode 010 - Mark Bamforth – building pharmaceutical manufacturing organisations to support innovators and to benefit patients
Manage episode 350522405 series 3394061
Content provided by Dr James McIlroy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr James McIlroy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Mark R. Bamforth is an entrepreneur, investor and mentor in life sciences. Mark has founded, built, and sold three contract development and manufacturing organisations (CDMOs) over the last 12 years.
His first company, Gallus Biopharmaceuticals, focused on monoclonal antibodies. His second company, Brammer Bio produced viral vectors for gene therapies. His third company. ArrantaBio, produced advanced therapies, including microbiome therapeutics.
Previously, Bamforth spent 22 years at Genzyme, latterly running global manufacturing operations. His career began as a petroleum engineer with Britoil, then as a chemical engineer with Whitbread.
Bamforth serves on the boards of Continuus Pharma, EnteroBiotix, Inceptor Bio, Pneumagen, and Entrepreneurial Scotland. He has a BS in Chemical Engineering from Strathclyde University and an MBA from Henley Management College.
53 episodes
Share
